↓ Skip to main content

Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy

Overview of attention for article published in Frontiers in immunology, July 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
13 X users
patent
2 patents
facebook
1 Facebook page

Citations

dimensions_citation
118 Dimensions

Readers on

mendeley
282 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy
Published in
Frontiers in immunology, July 2018
DOI 10.3389/fimmu.2018.01499
Pubmed ID
Authors

Yugang Guo, Kewen Lei, Li Tang

Abstract

Cancer neoantigens derived from random somatic mutations in tumor tissue represent an attractive type of targets for the cancer immunotherapies including cancer vaccine. Vaccination against the tumor-specific neoantigens minimizes the potential induction of central and peripheral tolerance as well as the risk of autoimmunity. Neoantigen-based cancer vaccines have recently showed marked therapeutic potential in both preclinical and early-phase clinical studies. However, significant challenges remain in the effective and faithful identification of immunogenic neoepitopes and the efficient and safe delivery of the subunit vaccine components for eliciting potent and robust anticancer T cell responses. In this mini review, we provide a brief overview of the recent advances in the development of neoantigen-based cancer vaccines focusing on various vaccine delivery strategies for targeting and modulating antigen-presenting cells. We discuss current delivery approaches, including direct injection, ex vivo-pulsed dendritic cell vaccination, and biomaterial-assisted vaccination for enhancing the efficiency of neoantigen vaccines and present a perspective on future directions.

X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 282 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 282 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 44 16%
Student > Bachelor 40 14%
Researcher 39 14%
Student > Master 31 11%
Student > Doctoral Student 11 4%
Other 34 12%
Unknown 83 29%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 54 19%
Immunology and Microbiology 32 11%
Agricultural and Biological Sciences 31 11%
Medicine and Dentistry 25 9%
Pharmacology, Toxicology and Pharmaceutical Science 12 4%
Other 43 15%
Unknown 85 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 May 2021.
All research outputs
#1,380,624
of 25,611,630 outputs
Outputs from Frontiers in immunology
#1,205
of 32,048 outputs
Outputs of similar age
#28,708
of 342,175 outputs
Outputs of similar age from Frontiers in immunology
#42
of 736 outputs
Altmetric has tracked 25,611,630 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,048 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 342,175 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 736 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.